FDA approves AstraZeneca`s Airsupra rescue inhaler, but only for adults
12 Jan 2023 //
FIERCE PHARMA
US FDA accepts NDA filed by Avillion for AstraZeneca`s PT027 ion asthma
31 May 2022 //
PRNEWSWIRE
PT027, significantly Reduced the Risk of a Severe Exacerbation by 27% in Asthma
15 May 2022 //
BUSINESSWIRE
Avillion/Merck psoriasis nanobody hits the mark in phase 2
27 Apr 2021 //
PHARMAPHORUM
Avillion`s positive Phase 2 trial of tri-specific Nanobody® sonelokimab (M1095)
22 Apr 2021 //
PRNEWSWIRE
Positive results from Avillion`s Phase 2 trial of sonelokinab M1095
29 Oct 2020 //
PRNEWSWIRE
Positive results from Avillion`s Phase 2 trial of sonelokinab (M1095)
29 Oct 2020 //
PRNEWSWIRE
Abingworth lines up $315M to bet on a new generation of transatlantic biotechs
09 Jul 2018 //
ENDPTS